StockGlow

HUTCHMED (China) Limited (H7T2.F)

HUTCHMED (China) Limited, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

1.81-0.03%Healthcare
Compare H7T2.F with
StockGlow Score
8
Bearish
BearishBullish
1 year ago-39.7%

The outlook

HUTCHMED (China) Limited currently reads as bearish based on below its 50- & 200-day averages, 12% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range12% of the way from its 52-week low to high
Market cap
$1.57B
52-wk high
3.02
52-wk low
1.65
50-day avg
1.84
200-day avg
2.19
Trailing P/E
90.5

Similar stocks

H7T1.FHUTCHMED (China) Limited$9.35-2.60%8AK.FAlkermes plc$43.26+3.42%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%HDP1.FArrowhead Pharmaceuticals, Inc.$75.18-0.56%NB3.FNeurocrine Biosciences, Inc.$145.00-7.73%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy